Patents by Inventor Charles E. Myers, Jr.

Charles E. Myers, Jr. has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of purinergic receptor agonists as antineoplastic agents
    Patent number: 5641500
    Abstract: The instant invention is directed to the use of a pharmaceutical composition containing an effective amount of adenosine or an adenosine analog or derivative as an agent useful in the treatment of hormone-independent cancers, such as prostate cancer. The invention is also directed to diagnostic uses of these compounds to determine effective treatment regimes for specific tumors, a process for screening for new, therapeutically useful analogs of these compounds, and the use of these compounds in facilitating the extraction of intracellular components.
    Type: Grant
    Filed: May 15, 1995
    Date of Patent: June 24, 1997
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: Jane B. Trepel, Wei-Gang Fang, Farzaneh Pirnia, Charles E. Myers, Jr.
  • Use of purinergic receptor agonists as antineoplastic agents
    Patent number: 5415873
    Abstract: The instant invention is directed to the use of a pharmaceutical composition containing an effective amount of adenosine or an adenosine analog or derivative as an agent useful in the treatment of hormone-independent cancers, such as prostate cancer. The invention is also directed to diagnostic uses of these compounds to determine effective treatment regimes for specific tumors, a process for screening for new, therapeutically useful analogs of these compounds, and the use of these compounds in facilitating the extraction of intracellular components.
    Type: Grant
    Filed: October 4, 1993
    Date of Patent: May 16, 1995
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: Jane B. Trepel, Wei-Gang Fang, Farzaneh Pirnia, Charles E. Myers, Jr.
  • N-Acetyl-cysteine protects against cardiac damage from subsequently-administered cardio-toxic anthra-cycline in cancer therapy
    Patent number: 4331648
    Abstract: The cardiac damage, occurring after treatment with an anthracycline, such as adriamycin, is prevented when N-acetyl-cysteine is orally administered about one hour prior to the treatment with the anthracycline.
    Type: Grant
    Filed: September 23, 1980
    Date of Patent: May 25, 1982
    Assignee: The United States of America as represented by the Secretary of the Department of Health and Human Services
    Inventors: Charles E. Myers, Jr., James H. Doroshow, Gershon Y. Locker